LOGIN
IV TXA Reduces Peri-Operative Blood Loss & Transfusion Requirement in Periacetabular Osteotomy
January 2021
IV TXA Reduces Peri-Operative Blood Loss & Transfusion Requirement in Periacetabular Osteotomy
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy
Bone Joint J. 2020 Sep;102-B(9):1151-1157Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Eighty-one patients scheduled to undergo elective periacetabular osteotomy (PAO) were randomized to receive IV tranexamic acid (TXA; n=40) or intravenous (IV) normal saline (n=41). The primary outcome of interest was total peri-operative calculated blood loss. The secondary outcomes of interest included the incidence of allogeneic transfusion, length of hospital stay, incidence of complications at...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.